Literature DB >> 26070759

"Addicted to Euphoria": The History, Clinical Presentation, and Management of Party Drug Misuse.

Jenny Bearn1, Matthew O'Brien2.   

Abstract

Eating, drinking, sexual activity, and parenting invoke pleasure, an emotion that promotes repetition of these behaviors, are essential for survival. Euphoria, a feeling or state of intense excitement and happiness, is an amplification of pleasure, aspired to one's essential biological needs that are satisfied. People use party drugs as a shortcut to euphoria. Ecstasy (3,4-methylenedioxymethamphetamine), γ-hydroxybutyric acid, and ketamine fall under the umbrella of the term "party drugs," each with differing neuropharmacological and physiological actions. This chapter seeks to survey the history and epidemiology of party drug use; we will then discuss the pharmacological characteristics of each drug to provide a platform for understanding the difficulties that party drug users encounter through intoxication, harmful use, dependence, and withdrawal and how these should be clinically managed.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GBH; MDMA; Party drugs

Mesh:

Substances:

Year:  2015        PMID: 26070759     DOI: 10.1016/bs.irn.2015.02.005

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  3 in total

1.  A comparison of self-reported sexual effects of alcohol, marijuana, and ecstasy in a sample of young adult nightlife attendees.

Authors:  Joseph J Palamar; Marybec Griffin-Tomas; Patricia Acosta; Danielle C Ompad; Charles M Cleland
Journal:  Psychol Sex       Date:  2018-01-08

2.  How Postmortem Redistribution of MDMA in Acute Alcohol-MDMA Combined-Use Rats Change under Effects of Alcohol.

Authors:  Man Liang; Jing Zhang; Na Zheng; Liang Liu
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

3.  Case Study: Naltrexone for the Treatment of Nitrous Oxide Use.

Authors:  Sarah Ickowicz; Rupinder Brar; Seonaid Nolan
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 4.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.